Supernus Pharmaceuticals, Inc. (FRA:S49)
38.60
+0.40 (1.05%)
At close: Dec 5, 2025
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of €2.25 billion as of December 5, 2025. Its market cap has increased by 22.26% in one year.
Market Cap
2.25B
Enterprise Value
2.05B
Revenue
580.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
€38.60
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from 97.10M to 2.25B, an increase of 2,218.84%. That is a compound annual growth rate of 26.00%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |